Multiple medication classes treat type 2 diabetes, each with different mechanisms. Understanding options helps you collaborate with your doctor on the best approach.
Metformin: The First-Line Agent
Metformin reduces glucose production in the liver and improves insulin sensitivity. It lowers A1c by 1-2% and does not cause weight gain. Side effects—usually gastrointestinal—diminish over weeks.
Metformin is remarkably safe with few serious side effects. Extended-release formulations reduce GI symptoms. Most people with type 2 diabetes start with metformin.
Sulfonylureas and Meglitinides
These drugs stimulate insulin release from the pancreas. They effectively lower glucose but carry hypoglycemia risk and may cause weight gain. They are typically second-line agents now that newer options exist.
GLP-1 Receptor Agonists
These drugs increase insulin secretion in response to glucose and slow gastric emptying. They lower A1c by 1-1.5% and often cause weight loss. Injectable and oral formulations exist.
GLP-1 agonists also have cardiovascular benefits—reducing heart attack and stroke risk. Recent data suggests they may improve beta cell function, potentially allowing tapering as glucose control improves.
SGLT2 Inhibitors
These drugs allow glucose excretion in urine. They lower A1c by 0.5-1%, usually cause modest weight loss, and improve blood pressure. Importantly, they reduce heart failure and chronic kidney disease progression.
SGLT2 inhibitors are increasingly used early in diabetes because of these extra-glycemic benefits.
DPP-4 Inhibitors
These preserve incretin hormone activity, increasing insulin secretion and reducing glucagon. They are weight-neutral and have good tolerability. However, blood pressure and cardiovascular benefits are minimal.
Combination Therapy
Often, multiple agents are necessary to achieve glucose targets. Combinations with different mechanisms work synergistically. Your doctor selects combinations based on your specific glucose patterns and comorbidities.
Beyond A1c
Modern diabetes management considers factors beyond glucose control: cardiovascular risk, kidney function, weight, and hypoglycemia risk. Choose medications addressing your specific needs.
← Back to Home